Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
about
Biomarkers in Pediatric ARDS: Future DirectionsA Dormant Microbial Component in the Development of PreeclampsiaThrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in JapanRevision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.Disseminated intravascular coagulation - new pathophysiological concepts and impact on management.Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.Evaluation of the Diagnostic Criteria for the Basic Type of DIC Established by the Japanese Society of Thrombosis and Hemostasis.The clinical practice guideline for the management of ARDS in Japan.Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.Sepsis: A Review of Advances in Management.New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide surveyThe application of anticoagulant therapy to sepsis.An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis.Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).Thrombomodulin, a Novel Immune Regulator in Liver Inflammatory Injury?Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
P2860
Q26744577-670740B0-996C-435D-8F79-E2486DA0C802Q28069689-81408D66-BA98-4469-B92C-6B0869ACCD31Q34501341-798EFF5D-75EE-44F3-8F69-2D873B9C7768Q35809477-7F8F4678-0465-40BD-AFF4-8618CE44A4A6Q37138741-97DB4DBE-7447-45BB-8832-8C96CC3447CCQ37258045-F8E16994-2393-4371-9967-42A0D8DEC690Q37319913-5D8FF6D4-20E4-4BAC-AB13-B6E8BD4CD72AQ38640508-913BCABB-E3D9-4BC8-A5DF-57896E4E53DCQ38851774-930F2132-C01F-4096-96F5-238DC43CFC59Q40455117-7706452A-8FA8-49E5-80C3-5DB47307BCB9Q40510077-250C8A9A-53D4-44F0-986B-9F94C2ED3AD9Q41117178-D53CF608-8C3A-4C03-8B46-C14D9C0C644EQ41504226-02F6F830-5563-4C38-8121-45DAA67E3207Q41918509-03DFA1B5-9749-45F4-82C8-145E3530B2CBQ41924557-B0C75F76-C6AF-4D70-878A-E78EDB03E17EQ41930088-C34F0ACB-F6DF-41DC-B893-0394CB882DA7Q42103342-C82E515D-FECE-4ACD-B044-3F527777EE0DQ43464051-E6306D27-0D5B-43F9-8B3E-CC110E0009A7Q47343207-3C555ABC-E31B-487D-A3D0-618E123CCBE9Q48371887-C2583A24-A066-4E8C-8B80-EA75F01D3649Q48516198-F0B7FA7B-AD8F-4DEF-BD61-36BACCA1CD3CQ50052469-84A0EB9A-9D49-4A10-A9D9-A86CD8E10B56Q54451103-8BBD0672-A6D1-4F6A-A6BC-E939F3A5D057Q56518823-15BA5ED6-543D-4B00-AA00-C3888A8E91CA
P2860
Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Recombinant human soluble thro ...... atic review and meta-analysis.
@en
type
label
Recombinant human soluble thro ...... atic review and meta-analysis.
@en
prefLabel
Recombinant human soluble thro ...... atic review and meta-analysis.
@en
P2093
P356
P1476
Recombinant human soluble thro ...... atic review and meta-analysis.
@en
P2093
P304
P356
10.1111/JTH.12841
P577
2015-03-05T00:00:00Z